Serina Therapeutics Inc.

Penny Stocks Biotech Stocks Healthcare Stocks

$2.01

-0.08 (-3.83%)

As of Sep 28, 10:36 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 5 83%

Hold 1 17%

Sell 0 0%

Price Target

Analyst Price Target +1,254.2% upside

Low Target $16.99

Average Target $27.22

High Target $37.92

Current Price $2.01

Current
$2.01

Target
$27.22

$16.99 $27.22 avg $37.92

Scenario Analysis

Bear Case

$16.99

745.3%

Low target

Base Case

$27.22

+1,254.2%

Avg target

Bull Case

$37.92

+1,786.6%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$5.83

-65.5% from high

52-Week Low

$1.22

+64.8% from low

Target vs 52W High

$27.22

+366.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%